Immunotherapy in pancreatic cancer: why do we keep failing? a focus on tumor immune microenvironment, predictive biomarkers and treatment outcomes

HIGHLIGHTS

  • who: Alessandro Di Federico and collaborators from the Division of Medical Oncology, Azienda Ospedaliero-Universitaria Bologna, Via Albertoni, Department of Specialized, Experimental and Diagnostic Medicine, University of Bologna, Via Giuseppe have published the paper: Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes, in the Journal: (JOURNAL)
  • what: In this paper provide comprehensive and up-to-date review of immunotherapy in PC from the analysis of the tumor immune microenvironment to immune biomarkers and treatment outcomes with the aim to highlight that simply transferring . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?